 |
 |
|
 |
|
|
Flavoxate HCI Tablets |
|
Strength |
Size |
NDC |
|
100 mg |
100 tablet
bottle |
0574-0115-01 |
Flavoxate HCl Tablets are contraindicated in patients who
have any of the following obstructive conditions: pyloric duodenal
obstruction, obstructive intestinal lesions or ileus, achalasia,
gastrointestinal hemorrhage and obstructive uropathies of the lower
urinary tract. Flavoxate HCl should be given cautiously in patients with
suspected glaucoma.
For wholesaler stocking numbers contact Paddock
Customer
Service.
 Read the Material Safety
Data Sheet
Read
the Flavoxate HCl
Prescribing Info
To read and print the data sheets, you will need to have Adobe Acrobat Reader installed on your computer. You can download a free copy by clicking on the following image.
*Urispas®
is a registered trademark of Ortho-McNeil Pharmaceuticals.
|
|
 |
|
